You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
The European Commission recently awarded the company a two-year, €2.6 million Horizon 2020 grant to achieve its ambitions.
Reveal Genomics plans to have assays available within three years, and is eager to partner with pharmaceutical and diagnostics companies to fulfill its vision.
Called CoronaDx, which has a budget of €3 million, aims to facilitate the development of testing systems for use in remote areas with limited infrastructure.
While the guidance was welcome after years of uncertainty, regulatory experts say it does not provide enough detail for IVD manufacturers.
A consortium led by the Barcelona-based company recently received €150,000 in EU funding to bring the platform to market.
The effort, called INNO4COV-19, was awarded €6.1 million last month to support the commercialization of new diagnostics.
The companies are positioning the test, called SeptiCyte Rapid, for use in triaging COVID-19 patients who could be at greater risk for progressing to sepsis.
The scientists received backing in the form of a €2.4 million EU grant this month and have founded a company, called Biopix-T, to commercialize the platform.